TP53 and neoplasm: Moreover, abnormal p53 expression or activity has become a marker for aggressive tumor behavior, resistance to treatment, and poor clinical results in a wide range of cancer types, including gastrointestinal disorders, laryngeal squamous cell carcinoma, cervical and breast cancers, and others.